Sun Pharma Advanced Research Company Limited (BOM:532872)

BOM:532872 Statistics

Total Valuation

BOM:532872 has a market cap or net worth of INR 69.06 billion. The enterprise value is 74.65 billion.

Market Cap	69.06B
Enterprise Value	74.65B

Important Dates

The last earnings date was Monday, May 18, 2026.

Earnings Date	May 18, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	324.52M
Shares Outstanding	n/a
Shares Change (YoY)	+0.00%
Shares Change (QoQ)	+0.09%
Owned by Insiders (%)	25.75%
Owned by Institutions (%)	6.83%
Float	91.39M

Valuation Ratios

The trailing PE ratio is 4.45.

PE Ratio	4.45
Forward PE	n/a
PS Ratio	176.41
PB Ratio	5.16
P/TBV Ratio	5.45
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.67, with an EV/FCF ratio of -28.43.

EV / Earnings	4.81
EV / Sales	190.67
EV / EBITDA	4.67
EV / EBIT	4.70
EV / FCF	-28.43

Financial Position

The company has a current ratio of 2.47, with a Debt / Equity ratio of 0.42.

Current Ratio	2.47
Quick Ratio	0.02
Debt / Equity	0.42
Debt / EBITDA	0.35
Debt / FCF	-2.13
Interest Coverage	46.54

Financial Efficiency

Return on equity (ROE) is 276.89% and return on invested capital (ROIC) is 101.82%.

Return on Equity (ROE)	276.89%
Return on Assets (ROA)	79.22%
Return on Invested Capital (ROIC)	101.82%
Return on Capital Employed (ROCE)	112.12%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	1.24M
Profits Per Employee	49.15M
Employee Count	316
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

Income Tax	-1.90M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +35.56% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+35.56%
50-Day Moving Average	159.72
200-Day Moving Average	141.04
Relative Strength Index (RSI)	63.35
Average Volume (20 Days)	609,078

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:532872 had revenue of INR 391.50 million and earned 15.53 billion in profits. Earnings per share was 47.86.

Revenue	391.50M
Gross Profit	155.50M
Operating Income	15.89B
Pretax Income	15.53B
Net Income	15.53B
EBITDA	15.99B
EBIT	15.89B
Earnings Per Share (EPS)	47.86

Balance Sheet

The company has 11.60 million in cash and 5.59 billion in debt, with a net cash position of -5.58 billion.

Cash & Cash Equivalents	11.60M
Total Debt	5.59B
Net Cash	-5.58B
Net Cash Per Share	n/a
Equity (Book Value)	13.39B
Book Value Per Share	41.25
Working Capital	11.08B

Cash Flow

In the last 12 months, operating cash flow was -2.39 billion and capital expenditures -238.30 million, giving a free cash flow of -2.63 billion.

Operating Cash Flow	-2.39B
Capital Expenditures	-238.30M
Depreciation & Amortization	102.10M
Net Borrowing	2.96B
Free Cash Flow	-2.63B
FCF Per Share	n/a

Margins

Gross margin is 39.72%, with operating and profit margins of 4,057.60% and 3,967.31%.

Gross Margin	39.72%
Operating Margin	4,057.60%
Pretax Margin	3,966.82%
Profit Margin	3,967.31%
EBITDA Margin	4,083.68%
EBIT Margin	4,057.60%
FCF Margin	n/a

Dividends & Yields

BOM:532872 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.00%
Shareholder Yield	-0.00%
Earnings Yield	22.49%
FCF Yield	-3.80%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3